AbbVie Reports Third-Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AbbVie (ABBV) Falls Following Q3 Release - Softness in US Sales Likely to 'Raise Concerns'
October 28, 2022 9:53 AM EDTAbbVie (NYSE: ABBV) shares are down more than 5% in early Friday trading after the company reported third-quarter earnings before the open, missing revenue expectations.
The company reported earnings of $3.66 per share, $0.08 better than the analyst estimate of $3.58, while revenue for the quarter came in at $14.81 billion versus the consensus estimate of $14.93 billion.
Following the report, Mizuho Securities analyst Uy Ear told investors in a note... More
AbbVie (ABBV) Raises Quarterly Dividend 5% to $1.48; 3.9% Yield
October 28, 2022 7:47 AM EDTAbbVie (NYSE: ABBV) declared a quarterly dividend of $1.48 per share, or $5.92 annualized. This is a 5% increase from the prior dividend of $1.41.
The dividend will be payable on February 15, 2023, to stockholders of record on January 13, 2023, with an ex-dividend date of January 12,... More
AbbVie (ABBV) Tops Q3 EPS by 8c, Updates FY EPS Guidance
October 28, 2022 7:45 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $3.66, $0.08 better than the analyst estimate of $3.58. Revenue for the quarter came in at $14.81 billion versus the consensus estimate of $14.93 billion.
GUIDANCE:
AbbVie sees FY2022 EPS of $13.84-$13.88, versus the consensus of $13.86.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
... More